Normal bone density and fat mass in heterozygous SERPINF1 mutation carriers

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 11, 2014, Pages E2446-E2450

  Al Jallad, Hadil ^a   Palomo, Telma ^a   Moffatt, Pierre ^a   Roughley, Peter ^a   Glorieux, Francis H ^a   Rauch, Frank ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

LIPID; PIGMENT EPITHELIUM DERIVED FACTOR; EYE PROTEIN; NERVE GROWTH FACTOR; PIGMENT EPITHELIUM-DERIVED FACTOR; SERINE PROTEINASE INHIBITOR;

ADOLESCENT; ADULT; AGED; ARTICLE; BODY COMPOSITION; BONE DENSITY; BONE METABOLISM; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FAT MASS; FEMALE; FRAMESHIFT MUTATION; GENE; GENE MUTATION; GENETIC TRANSCRIPTION; HETEROZYGOTE; HUMAN; HUMAN CELL; HUMAN TISSUE; LUMBAR SPINE; MALE; OSTEOGENESIS IMPERFECTA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RADIUS; SERPINF1 GENE; SKIN FIBROBLAST; TIBIA; FIBROBLAST; GENETICS; METABOLISM; MIDDLE AGED; MUTATION; NUCLEOTIDE SEQUENCE; OBESITY; SKIN; VERY ELDERLY; YOUNG ADULT;

ADIPOSITY; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BONE DENSITY; CHILD; DNA MUTATIONAL ANALYSIS; EYE PROTEINS; FEMALE; FIBROBLASTS; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; MUTATION; NERVE GROWTH FACTORS; SERPINS; SKIN; YOUNG ADULT;

EID: 84910019796     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-2505     Document Type: Article

References (18)

1. Glorieux FH, Ward LM, Rauch F, Lalic L, Roughley PJ, Travers R. Osteogenesis imperfecta type VI: a form of brittle bone disease with a mineralization defect. J Bone Miner Res. 2002; 17: 30-38.
2. Homan EP, Rauch F, Grafe I, et al. Mutations in SERPINF1 cause osteogenesis imperfecta type VI. J Bone Miner Res. 2011; 26: 2798-2803.
3. Crowe S, Wu LE, Economou C, et al. Pigment epithelium-derived factor contributes to insulin resistance in obesity. Cell Metab. 2009; 10: 40-47.
4. Yamagishi S, Adachi H, Abe A, et al. Elevated serum levels of pigment epithelium-derived factor in the metabolic syndrome. J Clin Endocrinol Metab. 2006; 91: 2447-2450.
5. Sabater M, Moreno-Navarrete JM, Ortega FJ, et al. Circulating pigment epithelium-derived factor levels are associated with insulin resistance and decrease after weight loss. J Clin Endocrinol Metab. 2010; 95: 4720-4728.
6. Becker J, Semler O, Gilissen C, et al. Exome sequencing identifies truncating mutations in human SERPINF1 in autosomal-recessive osteogenesis imperfecta. Am J Hum Genet. 2011; 88: 362-371.
7. Rauch F, Husseini A, Roughley P, Glorieux FH, Moffatt P. Lack of circulating pigment epithelium-derived factor is a marker of osteogenesis imperfecta type VI. J Clin Endocrinol Metab. 2012; 97: E1550-E1556.
8. Tucker T, Nelson T, Sirrs S, et al. A co-occurrence of osteogenesis imperfecta type VI and cystinosis. Am J Med Genet A. 2012; 158A: 1422-1426.
9. Venturi G, Gandini A, Monti E, et al. Lack of expression of SERPINF1, the gene coding for pigment epithelium-derived factor, causes progressively deforming osteogenesis imperfecta with normal type I collagen. J Bone Miner Res. 2012; 27: 723-728.
10. Gong Y, Slee RB, Fukai N, et al. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell. 2001; 107: 513-523.
11. Keupp K, Beleggia F, Kayserili H, et al. Mutations in WNT1 cause different forms of bone fragility. Am J Hum Genet. 2013; 92: 565-574.
12. Laine CM, Joeng KS, Campeau PM, et al. WNT1 mutations in early-onset osteoporosis and osteogenesis imperfecta.NEngl JMed. 2013; 368: 1809-1816.
13. Ogden CL, Kuczmarski RJ, Flegal KM, et al. Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics. 2002; 109: 45-60.
14. Rauch F, Schoenau E. Peripheral quantitative computed tomography of the distal radius in young subjects-new reference data and interpretation of results. J Musculoskelet Neuronal Interact. 2005; 5: 119-126.
15. Rauch F, Schoenau E. Peripheral quantitative computed tomography of the proximal radius in young subjects-new reference data and interpretation of results. J Musculoskelet Neuronal Interact. 2008; 8: 217-226.
16. Stejskal D, Karpisek M, Svestak M, Hejduk P, Sporova L, Kotolova H. Pigment epithelium-derived factor as a new marker of metabolic syndrome in Caucasian population. J Clin Lab Anal. 2010; 24: 17-19.
17. Gattu AK, Swenson ES, Iwakiri Y, et al. Determination of mesenchymal stem cell fate by pigment epithelium-derived factor (PEDF) results in increased adiposity and reduced bone mineral content. FASEB J. 2013; 27: 4384-4394.
18. Lakeland TV, Borg ML, Matzaris M, Abdelkader A, Evans RG, Watt MJ. Augmented expression and secretion of adipose-derived pigment epithelium-derived factor does not alter local angiogenesis or contribute to the development of systemic metabolic derangements. Am J Physiol Endocrinol Metab. 2014; 306: E1367-E1377.